Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.

Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.

BACKGROUND:Evidences linking treatment with inhibitors of gastric acid secretion (IGAS) and an increased risk of serious infections are inconclusive, both in the population at large and in the particular case of patients with chronic kidney disease. We have undertaken an investigation to disclose as...

Full description

Bibliographic Details
Main Authors: Miguel Pérez-Fontan, Daniela Machado Lopes, Alba García Enríquez, Beatriz López-Calviño, Andrés López-Muñiz, Teresa García Falcón, Ana Rodríguez-Carmona
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4752472?pdf=render

Internet

http://europepmc.org/articles/PMC4752472?pdf=render

Similar Items